LGI Homes enters the back half of May with a notable disconnect — short sellers sit near their highest conviction levels in months, while options traders have abruptly swung to one of their most bullish readings of the past year.
Short interest has climbed steadily and is now a genuinely elevated 14.7% of the free float — up from roughly 13.4% in late April and sitting near the top of its recent range. The past month saw a 10% increase in shares borrowed, a build that coincides with the stock losing 7% over the same period. Days to cover run close to five days on official FINRA data, meaning any sustained buying pressure would take time to unwind that position. The borrow market itself remains relaxed: availability is very loose at around 720% — nearly seven shares available for every one already borrowed — and the cost to borrow has nudged only slightly higher to 0.54%, well inside "easy" territory. Shorts face no squeeze pressure in the lending pool right now.
The options picture tells a sharply different story. Call positioning has surged to the most aggressive bullish lean in recent memory, with the put/call ratio dropping to 0.58 — nearly two and a half standard deviations below its 20-day average of 0.86. That is close to the 52-week low of 0.15 on the bullish side, a sharp reversal from the 1.0-plus readings that dominated through April. Whether that reflects a contrarian bet on a bounce or hedged institutional positioning, options traders are not positioned for further deterioration. The two camps — elevated short interest and unusually bullish options — are pulling in opposite directions this week.
The Street is broadly divided. The analyst consensus mean price target of $67 implies more than 65% upside from current levels at $40.57, yet the most recent notable action came from JP Morgan's Michael Rehaut, who on April 30 raised his target from $38 to $41 while keeping an Underweight rating — a signal that even the bear camp sees less downside than it did, but is nowhere near capitulating. The bull case centres on a margin recovery story: net margins reportedly moved from 1.8% to 8.7% over recent quarters, and the company's entry-level focus positions it favourably for any demand recovery. Bears push back on slowing unit economics: absorption pace has slipped to around 2.6 closings per month, and the Central segment — largely Texas — has been squeezed by local competition. At a price-to-book of roughly 0.49 and a trailing P/E near 10.9, the valuation multiples do not look demanding, but the EV/EBITDA has expanded by nearly 6 turns over 30 days as EBITDA estimates shift, which complicates the cheap-stock narrative. The RSI14 has eased to 39, suggesting the stock is technically oversold but not yet at capitulation levels.
The institutional picture carries one point worth noting. Millennium Management and Marshall Wace both added material new positions as of the March 31 filing — Millennium added roughly 470k shares and Marshall Wace built a position of nearly 459k shares from scratch. Both are well-known quantitative and event-driven shops. That is recent accumulation at levels near or above the current price, not fresh buying. On the other side, Wasatch Advisors trimmed by approximately 448k shares in the same period, a meaningful reduction from a traditionally long-biased manager. Insider activity from March shows the CEO and President each sold shares in the $41-$43 range — prices that are now above where the stock trades — modest in absolute size but worth noting given the current level.
The next confirmed catalyst is Q1 2026 results, due July 28. The most recent print — last reported at the end of April — produced a 5.8% one-day gain, the best single-session reaction in recent history. With short interest elevated, options unusually bullish, and the stock down 11% on the week while peers like CCS fell 8.7% and TMHC dropped 5.3%, the setup into that July print is where convergence — or continued divergence — between these positioning camps will matter most.
See the live data behind this article on ORTEX.
Open LGIH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
